Announcements Trials
Browse Landscape

Phase

Phase NA 28Phase 4 5Phase 2 5Phase 3 3Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 4Terminated 1

Sponsor Class

INDUSTRY 3OTHER 1NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 3

Conditions

Breast Neoplasms 2760Carcinoma, Non-Small-Cell Lung 2260Prostatic Neoplasms 1425Colorectal Neoplasms 1290Neoplasms 1258Multiple Myeloma 1084Lung Neoplasms 1048Neoplasm Metastasis 994Leukemia, Myeloid, Acute 984Lymphoma 900Melanoma 862Pancreatic Neoplasms 818Ovarian Neoplasms 805Carcinoma, Hepatocellular 782Stomach Neoplasms 753Recurrence 750Leukemia 733Lymphoma, Non-Hodgkin 684Leukemia, Lymphocytic, Chronic, B-Cell 665Lymphoma, Large B-Cell, Diffuse 616Squamous Cell Carcinoma of Head and Neck 615Precursor Cell Lymphoblastic Leukemia-Lymphoma 605Head and Neck Neoplasms 596Brain Neoplasms 592Carcinoma, Renal Cell 586Glioblastoma 572Rectal Neoplasms 563Myelodysplastic Syndromes 522Sarcoma 521Lymphoma, Follicular 516

Interventions

Etanercept 2NVP-QAV680 1Beclomethasone 1Azithromycin 1Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Asthma × Clear all
NCT02517099 2023-03-06

PrIGMa

Imperial College London

Phase 2 Completed
60 enrolled 10 charts
Lymphoid

Asthma, Lymphoma, Follicular, Respiratory Sounds

NCT01103037 2020-12-19

Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma

Novartis

Phase 2 Terminated
8 enrolled
Lymphoid

Asthma, Lymphoma, Follicular

NCT00001893 2017-07-02

Study of TNFR:Fc (Enbrel) in the Treatment of Asthma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
150 enrolled

Asthma

NCT02105012 2017-06-06

Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma

Pearl Therapeutics, Inc.

Phase 2 Completed
147 enrolled 10 charts
Lymphoid

Asthma, Lymphoma, Follicular

NCT00141791 2009-08-07

Study Evaluating Etanercept in Moderate to Severe Asthma

Wyeth is now a wholly owned subsidiary of Pfizer

Phase 2 Completed
120 enrolled

Asthma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡